EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma

EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma

Abstract Background Lung cancer is one of the most incident neoplastic diseases, and a leading cause of death for cancer worldwide. Knowledge of the incidence of druggable genetic alterations, their correlation with clinical and pathological features of the disease, and their interplay in cases of c...

Full description

Bibliographic Details
Main Authors: Maria Colombino, Panagiotis Paliogiannis, Antonio Cossu, Davide Adriano Santeufemia, Sardinian Lung Cancer (SLC) Study Group, Maria Cristina Sini, Milena Casula, Grazia Palomba, Antonella Manca, Marina Pisano, Valentina Doneddu, Giuseppe Palmieri
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Pulmonary Medicine
Subjects:
Lung cancer
Adenocarcinoma
Targeted therapies
EGFR
KRAS
BRAF
Online Access:http://link.springer.com/article/10.1186/s12890-019-0964-x

Internet

http://link.springer.com/article/10.1186/s12890-019-0964-x

Similar Items